Preparation of noninfectious scRNAseq samples from SARS-CoV-2-infected epithelial cells
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0281898 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Raven M Osborn und 11 weiteren Autor:innen. Beteiligte Einrichtung: Translational Biomedical Sciences Program, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS coronavirus 2 (SARS-CoV-2) virus. Direct assessment, detection, and quantitative analysis using high throughput methods like single-cell RNA sequencing (scRNAseq) is imperative to understanding the host response to SARS-CoV-2. One barrier to studying SARS-CoV-2 in the laboratory setting is the requirement to process virus-infected cell cultures, and potentially infectious materials derived therefrom, under Biosafety Level 3 (BSL-3) containment. However, there are only 190 BSL3 laboratory facilities registered with the U.S. Federal Select Agent Program, as of 2020, and only a subset of these are outfitted with the equipment needed to perform high-throughput molecular assays. Here, we describe a method for preparing non-hazardous RNA samples from SARS-CoV-2 infected cells, that enables scRNAseq analyses to be conducted safely in a BSL2 facility–thereby making molecular assays of SARS-CoV-2 cells accessible to a much larger community of researchers. Briefly, we infected African green monkey kidney epithelial cells (Vero-E6) with SARS-CoV-2 for 96 hours, trypsin-dissociated the cells, and inactivated them with methanol-acetone in a single-cell suspension. Fixed cells were tested for the presence of infectious SARS-CoV-2 virions using the Tissue Culture Infectious Dose Assay (TCID50), and also tested for viability using flow cytometry. We then tested the dissociation and methanol-acetone inactivation method on primary human lung epithelial cells that had been differentiated on an air-liquid interface. Finally, we performed scRNAseq quality control analysis on the resulting cell populations to evaluate the effects of our virus inactivation and sample preparation protocol on the quality of the cDNA produced. We found that methanol-acetone inactivated SARS-CoV-2, fixed the lung epithelial cells, and could be used to obtain noninfectious, high-quality cDNA libraries. This methodology makes investigating SARS-CoV-2, and related high-containment RNA viruses at a single-cell level more accessible to an expanded community of researchers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Translational Biomedical Sciences Program, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
- Clinical and Translational Sciences Institute, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
- Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
- Genomics Research Center, Center for Advanced Research Technologies, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
- Department of Pediatrics and Center for Children's Health Research, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
- Biophysics, Structural, and Computational Biology Program, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
ORCID-Profile: Raven M Osborn, Christopher S Anderson
Förderung
- NIEHS NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
- Burroughs Wellcome Fund
- National Center for Advancing Translational Sciences
- NHLBI Division of Intramural Research
- Technology Development Fund Award, School of Medicine and Dentistry, University of Rochester
- Scientific Advisory Committee Incubator Award, School of Medicine and Dentistry, University of Rochester
Zitieren
APA
Osborn, R. M., Leach, J., Zanche, M., Ashton, J. M., Chu, C., Thakar, J., Dewhurst, S., Rosenberger, S., Pavelka, M., Pryhuber, G. S., Mariani, T. J., & Anderson, C. S. (2023). Preparation of noninfectious scRNAseq samples from SARS-CoV-2-infected epithelial cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0281898
Vancouver
Osborn RM, Leach J, Zanche M, Ashton JM, Chu C, Thakar J, et al. Preparation of noninfectious scRNAseq samples from SARS-CoV-2-infected epithelial cells. PLOS ONE. 2023. doi:10.1371/journal.pone.0281898
BibTeX
@article{Osborn2023,
author = {Osborn, Raven M and Leach, Justin and Zanche, Michelle and Ashton, John M and Chu, ChinYi and Thakar, Juilee and Dewhurst, Stephen and Rosenberger, Sonia and Pavelka, Martin and Pryhuber, Gloria S and Mariani, Thomas J and Anderson, Christopher S},
title = {Preparation of noninfectious scRNAseq samples from SARS-CoV-2-infected epithelial cells},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0281898}
}
EUVIMED